A nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome at the early stage—A multicenter study in China
Authors:
Open Access
- 25 November 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 13 (11) , e0007829
Abstract
Severe fever with thrombocytopenia syndrome (SFTS) caused by the SFTS virus is an emerging infectious disease that was first identified in the rural areas of China in 2011. Severe cases often result in death due to multiple organ failure. To date, there are still numerous problems remain unresolved in SFTS, including unclear pathogenesis, lack of specific treatment, and no effective vaccines available. To analyze the clinical information of patients with early-stage SFTS and to establish a nomogram for the mortality risk. Between April 2011 and December 2018, data on consecutive patients who were diagnosed with SFTS were prospectively collected from five medical centers distributed in central and northeastern China. Multivariable Cox analyses were used to identify the factors independently associated with mortality. A nomogram for mortality was established using those factors. During the study period, 429 consecutive patients were diagnosed with SFTS at the early stage of the disease (within 7 days of fever), among whom 69 (16.1%) died within 28 days. The multivariable Cox proportional hazard regression analysis showed that low lymphocyte percentage, early-stage encephalopathy, and elevated concentration of serum LDH and BUN were independent risk factors for fatal outcomes. Received-operating characteristic curves for 7-, 14-, and 28-days survival had AUCs of 0.944 (95% CI: 0.920–0.968), 0.924 (95% CI: 0.896–0.953), and 0.924 (95% CI: 0.895–0.952), respectively. Among low-risk patients, 6 patients died (2.2%). Among moderate-risk patients, 25 patients died (24.0%, hazard ratio (HR) = 11.957). Among high-risk patients, the mortality rate was 69.1% (HR = 57.768). We established a simple and practical clinical scoring system, through which we can identify critically ill patients and provide intensive medical intervention for patients as soon as possible to reduce mortality. We established a SFTS nomogram scoring system, which is the first nomogram for this disease. According to this nomogram, patients were divided into three levels of mortality risk: low, moderate, and high. This scoring system is helpful to identify critically ill patients, allowing for early intervention and intensive care, which may contribute to reducing the mortality of SFTS.Keywords
Funding Information
- Special Fund For High-level Talents in Beijing Health System Project (2011-3-079)
- Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (XMLX201502 and XMLX201602)
- National Science and Technology Major Project of China (2018ZX09711003)
This publication has 45 references indexed in Scilit:
- Indices to Measure Risk of HIV Acquisition in Rakai, UgandaPLOS ONE, 2014
- Co-Circulation of Multiple Hemorrhagic Fever Diseases with Distinct Clinical Characteristics in Dandong, ChinaPLOS ONE, 2014
- The First Identification and Retrospective Study of Severe Fever With Thrombocytopenia Syndrome in JapanThe Journal of Infectious Diseases, 2013
- Clinical Features and Factors Associated with Severity and Fatality among Patients with Severe Fever with Thrombocytopenia Syndrome Bunyavirus Infection in Northeast ChinaPLOS ONE, 2013
- Clinical Progress and Risk Factors for Death in Severe Fever with Thrombocytopenia Syndrome PatientsThe Journal of Infectious Diseases, 2012
- Fever with Thrombocytopenia Associated with a Novel Bunyavirus in ChinaNew England Journal of Medicine, 2011
- Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective studyThe Lancet Infectious Diseases, 2010
- Nomograms for staging, prognosis, and predicting treatment outcomesCancer, 2009
- Evidence for the usefulness of nomogramsNature Reviews Endocrinology, 2007
- X-TileClinical Cancer Research, 2004